Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate.
about
Current understanding of interactions between nanoparticles and the immune systemProgress in intra-articular therapyAdjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrixContinuous synthesis of drug-loaded nanoparticles using microchannel emulsification and numerical modeling: effect of passive mixing.Current advances in research and clinical applications of PLGA-based nanotechnology.Nanoparticles and the immune systemProduction, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles.Drug delivery systems for the treatment of sensorineural hearing loss.Dexamethasone Release from Within Engineered Cartilage as a Chondroprotective Strategy Against Interleukin-1α.Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications.Nanomedicine strategies for drug delivery to the ear.Applications of nanotechnology for immunology.Recent advances in nanomedicines for the treatment of rheumatoid arthritis.Intra-articular interleukin-1 receptor antagonist (IL1-ra) microspheres for posttraumatic osteoarthritis: in vitro biological activity and in vivo disease modifying effectFormulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice.Effects of Inflammation on Multiscale Biomechanical Properties of Cartilaginous Cells and Tissues.Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.Towards an arthritis flare-responsive drug delivery system.Mesenchymal stromal cells versus betamethasone can dampen disease activity in the collagen arthritis mouse model.
P2860
Q26345204-4164958F-3BF3-486E-9E63-A1701B3DFF89Q26851258-C2932530-B7A9-4BD9-9F00-013FD42A6C0CQ27303877-1CA9E2BB-3222-49E5-BC3A-1372AB106072Q30376578-ACC31F46-0EB9-4CC4-9905-82B7EC6B8777Q30482916-3F27931D-3469-45C1-A203-95AE0B3257CFQ33634320-8F57EF4D-429F-4AB5-968D-5E925E00B77BQ35138923-5EE7956B-C4D2-4003-92E5-D2BBCC2BB8ABQ36799313-26CB3E1B-BF83-45CF-9616-214C010E1DEBQ36825938-0531D5D9-9120-4148-BFAF-E6F29CBEB0F6Q37176404-210B9CFA-188D-4D53-9B9C-169CF80DACCFQ38120319-33AE8E4B-7CCB-448F-888D-AAF9A685047CQ38123937-2DFCBBF2-A71C-4F23-8F9B-B8B2D47A4707Q38669113-3DA7488C-BBCF-467C-AA2F-85E7F0DC475EQ41579564-822728BA-5803-4E35-9BB0-FE20B3A7CF40Q41904451-3D500793-7494-48F5-BFCC-82BCD78148DBQ42370730-1773F913-024D-438C-9050-C92B374BF802Q47125223-3AB36D14-0F28-49ED-8E22-51781BE8B72AQ48234892-6F5B60EA-DBE5-407F-86DA-98C4AB770182Q52721914-303D5DC8-AECB-4C8E-B274-DAD921E68896Q53092392-40A09E6F-A917-4AF5-B26D-4C7DB9AF2C18
P2860
Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Treatment of experimental arth ...... etamethasone sodium phosphate.
@ast
Treatment of experimental arth ...... etamethasone sodium phosphate.
@en
type
label
Treatment of experimental arth ...... etamethasone sodium phosphate.
@ast
Treatment of experimental arth ...... etamethasone sodium phosphate.
@en
prefLabel
Treatment of experimental arth ...... etamethasone sodium phosphate.
@ast
Treatment of experimental arth ...... etamethasone sodium phosphate.
@en
P2093
P2860
P356
P1476
Treatment of experimental arth ...... etamethasone sodium phosphate.
@en
P2093
P2860
P304
P356
10.1136/ARD.2004.030759
P407
P577
2005-02-04T00:00:00Z